Perfusion Medical
Reston
About Perfusion Medical
Perfusion Medical is an emerging biopharmaceutical company developing life-saving, acute cardiovascular therapies to transform critical care medicine, with a focus on shock and ischemic conditions. The company’s lead candidate, PM-208, is designed to rapidly restore microvascular perfusion, resolving ischemia and protecting vital organs. Preclinical data suggest that PM-208 has the potential to improve survival outcomes, accelerate patient recovery, and reduce long-term comorbidities in conditions such as hemorrhagic shock, cardiogenic shock, and acute kidney injury.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $10.0M
- Funding stage: Seed
- Last round: Seed (Dec 2024)
- Website: perfusionmedical.com
Industries & Categories
Medical
Social Profiles
Canonical: https://fsome.com/organization/perfusion-medical-112847 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.